Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Tian, J. Mysliwietz, J. Ellwart, F. Gamarra, R. Huber, A. Bergner (Munich, Germany). Late Breaking Abstract: Effect of the hedgehog pathway inhibitor GDC-0449 on side populations in lung cancer cell lines. Eur Respir J 2010; 36: Suppl. 54, 3682

Member's Comments

No comment yet.

Related content which might interest you: LSC 2012 abstract – Effects of the Hedgehog (Hh) pathway inhibitor GDC-0449 on lung cancer cells and cisplatin resistant lung cancer cells are mediated by lung cancer stem cells (SPs) Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Late Breaking Abstract - Membrane bile acid receptor contributes to the proliferation of lung cancer cells induced by lung fibroblast-tumor cells  interaction though TLR4/NF-kB signaling pathway Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effect of rHuKGF in vegf dependent cell survival progression in emphysematous condition via akt signalling pathway Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Leptin and apigenin: antagonists in the apoptotic pathway of lung adenocarcinoma cell line Source: Eur Respir J 2006; 28: Suppl. 50, 668s Year: 2006 Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 326s Year: 2006 Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006 Met amplification induces an aggressive phenotype in EGFR tyrosine kinase inhibitors resistant non-small-cell lung cancer Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010